Landfar Bio-medicine Co., Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 25.97 million compared to CNY 34.74 million a year ago. Net loss was CNY 2.77 million compared to CNY 1.98 million a year ago.

Basic loss per share from continuing operations was CNY 0.0084 compared to CNY 0.0063 a year ago. Diluted loss per share from continuing operations was CNY 0.0084 compared to CNY 0.0063 a year ago.